2024-05-19
2024-02-08
Summary | |
---|---|
Cancer Type | Colorectal Cancer |
Grade | T4 N0 Mx V1 Pn0 G2 |
Stage | NA |
Ethnicity | Western |
Gender | M |
Age | 50 |
Pathology Diagnosis | multiple liver mets; tumor size: 7 x 1 & 6 x 2. Post Op survival: 1 year. |
Biopsy Site | Hepatectomy |
Treatment History | Pre op adjuvant chemotherapy 8 cycles - Oxaliplatin / Capecitabine |
Pathology QC | Well to moderately differentiated adenocarcinoma (P9). IHC (P8, P11): HepPar1 (+/-), AFP (-), CDX2 (3+), CK20 (1+), CK7 (-) |
Special Features | NA |
Mouse Strain | NOD SCID |
TMA | TMA-HP-CR-030 |
Viral Status in PDX | NA |
Available In | CB_CN |
RNA Seq | P11 |
Exome Seq | P11 |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy